Latest Islet cell transplantation Stories
DiaKine Therapeutics, a development-stage company commercializing immune modulators for the treatment of diabetes and related complications, has announced that a Phase II clinical trial with the company's lead drug candidate, Lisofylline, is underway.
DiaKine Therapeutics, developers of drugs designed to cause diabetes to go into remission, announced today that a Phase 2 Clinical Trial with the Company's lead drug candidate, Lisofylline (LSF), is underway.
As a world leader in organ transplantation, UCSF will celebrate its 45th year of transplantation with a week of exciting workshops, lectures and forums.
Doctors in Houston are testing a procedure that transfers pancreatic cells into arms or legs to provide insulin for patients who have lost their pancreas. The work at Houston's Methodist Hospital builds on a small study in Sweden, the Houston Chronicle reports.
WASHINGTON, July 30 /PRNewswire-FirstCall/ -- The ability of blood tests to precisely measure very low doses of anti-rejection drugs in kidney transplant patients may make a significant difference in assuring long-term viability and survival, according to research presented today at the American Association for Clinical Chemistry (AACC) annual meeting.
One day it may be possible to mimic the tactics used by parasites to trick the body into accepting transplanted tissues or organs.
Demi-Lee Brennan, a 15-year-old Australian transplant recipient has become the first person in the world to change blood groups and assume the immune system of her donor.
Reportlinker.com announces that a new market research report related to the Health Care industry is available in its catalogue.
SAN DIEGO, June 26, 2007 (PRIME NEWSWIRE) -- MicroIslet, Inc. (OTCBB:MIIS) (the "Company") announced today that Jonathan R. T. Lakey, Ph.D., M.S.M., was named the Company's Chief Scientific Officer and elected to the Company's Board of Directors. Dr.
In certain patients with diabetes-related kidney disease, performing a transplant before the need for dialysis arises seems to be advantageous, researchers report.
- A mania for the use of printing-types; a strong propensity to write for publication.